Maxime Blijlevens

A genome‐wide si<scp>RNA</scp> screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the <scp>RNA</scp> splicing machinery as targets for anticancer treatment

Ellen Siebring‐van Olst, Maxime Blijlevens, Renée X. de Menezes et al. · Molecular Oncology · 2017 · 71 citations · Full text

Tumor Biology, Radiation Oncology, Spliceosome Components +15

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Rocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni et al. · EBioMedicine · 2018 · 64 citations · Full text

Medicine, Immunology, Pathology +6

Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome

Shen He, Maxime Blijlevens, Nuo Yang et al. · International Journal of Biological Sciences · 2015 · 40 citations · Full text

Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets

Costa Frangou, Yingwei Li, He Shen et al. · Oncotarget · 2014 · 28 citations · Full text

High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome

Maxime Blijlevens, Ida H. van der Meulen‐Muileman, Renée X. de Menezes et al. · Oncogene · 2019 · 27 citations

Tumor Biology, Functional Genomics, Engineering +10